HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Shiseido

This article was originally published in The Rose Sheet

Executive Summary

Japanese firm expects to record $41.8 mil. (Y1=$.008) net loss for fiscal first half (ended Sept. 30), company announces as part of revised earnings forecast. Loss will reflect Shiseido's decision to remove products that do not meet Japan's new Pharmaceutical Affairs Law labeling requirements and replace them with updated labels ahead of deadline to avoid consumer confusion, firm says. Shiseido predicted net income of $25 mil. in May. Estimated first half net sales of $2.42 bil. will remain unchanged. For the year, Shiseido expects to record net loss of $75.2 mil. rather than income of $83.5 mil., while net sales expected to be $5.01 bil. remains unchanged
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS009695

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel